Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James Paul Scopa currently holds 60,000 shares of Adverum Biotechnologies, Inc. (ADVM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Paul Scopa has been a net buyer of ADVM stock. They have purchased $6.3M and sold $399.5K worth of shares.
James Paul Scopa's most recent insider trade was on Dec 9, 2025, when they sold 10,333 shares at $0.00 per share.
James Paul Scopa serves as Executive at Adverum Biotechnologies, Inc. (ADVM). They have executed 58 insider transactions totaling $6.7M over their tenure at the company.
James Paul Scopa holds the position of Executive at Adverum Biotechnologies, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
James Paul Scopa has shown a buying trading pattern, with $6.3M in total purchases and $399.5K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by James Paul Scopa was on Feb 8, 2011, when they purchased $1.9M worth of PCRX shares. This transaction involved 267,857 shares at $7.00 per share.
James Paul Scopa currently owns 60,000 shares of Adverum Biotechnologies, Inc. (ADVM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James Paul Scopa's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James Paul Scopa has 58 Form 4 filings on record as an insider at Adverum Biotechnologies, Inc..
Set alerts for James Paul Scopa and 40,000+ other insiders.